Simulations Plus, Inc. (NASDAQ:SLP) Given Consensus Rating of “Reduce” by Analysts

Simulations Plus, Inc. (NASDAQ:SLPGet Free Report) has earned an average rating of “Reduce” from the eight analysts that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $17.25.

SLP has been the subject of a number of recent research reports. Weiss Ratings upgraded Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, July 10th. Craig Hallum lowered shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price objective for the company. in a report on Thursday, June 18th. Wall Street Zen cut shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. Finally, William Blair lowered shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a report on Wednesday, June 17th.

Check Out Our Latest Analysis on Simulations Plus

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 4,177 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total transaction of $77,023.88. Following the completion of the sale, the director directly owned 3,202,131 shares in the company, valued at $59,047,295.64. This represents a 0.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 19.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Simulations Plus

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. First Light Asset Management LLC grew its position in Simulations Plus by 33.7% during the 1st quarter. First Light Asset Management LLC now owns 2,632,823 shares of the technology company’s stock worth $31,120,000 after acquiring an additional 663,906 shares during the last quarter. BlackRock Inc. bought a new stake in Simulations Plus in the second quarter valued at approximately $27,503,000. Ameriprise Financial Inc. lifted its position in Simulations Plus by 25.3% in the second quarter. Ameriprise Financial Inc. now owns 875,447 shares of the technology company’s stock valued at $15,277,000 after purchasing an additional 176,747 shares during the last quarter. Marshall Wace LLP boosted its stake in shares of Simulations Plus by 127.5% during the fourth quarter. Marshall Wace LLP now owns 569,783 shares of the technology company’s stock valued at $10,387,000 after purchasing an additional 319,301 shares during the period. Finally, Stephens Investment Management Group LLC boosted its stake in shares of Simulations Plus by 30.8% during the fourth quarter. Stephens Investment Management Group LLC now owns 513,728 shares of the technology company’s stock valued at $9,365,000 after purchasing an additional 120,888 shares during the period. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Price Performance

Shares of Simulations Plus stock opened at $18.35 on Thursday. Simulations Plus has a 1 year low of $11.09 and a 1 year high of $21.01. The firm has a market cap of $371.22 million, a PE ratio of 45.88 and a beta of 1.32. The company has a 50 day simple moving average of $17.87 and a two-hundred day simple moving average of $15.34.

Simulations Plus (NASDAQ:SLPGet Free Report) last issued its quarterly earnings results on Thursday, July 9th. The technology company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.07. Simulations Plus had a net margin of 9.88% and a return on equity of 13.50%. The firm had revenue of $21.89 million for the quarter, compared to analyst estimates of $20.90 million. As a group, research analysts anticipate that Simulations Plus will post 0.8 earnings per share for the current year.

Simulations Plus Company Profile

(Get Free Report)

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.

Featured Stories

Analyst Recommendations for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.